AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,052,950 | -3.2% | 172,456 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $12,448,452 | +15.9% | 173,232 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $10,742,000 | +83003.8% | 174,156 | +3.9% | 0.00% | -50.0% |
| Q4 2022 | $12,926 | -99.8% | 167,577 | -2.5% | 0.00% | +100.0% |
| Q3 2022 | $7,670,000 | +14.0% | 171,878 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $6,729,000 | -7.7% | 175,701 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $7,288,000 | +10.1% | 176,086 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $6,620,000 | +660.0% | 175,243 | +562.2% | 0.00% | – |
| Q3 2021 | $871,000 | -48.8% | 26,463 | +5.0% | 0.00% | – |
| Q2 2021 | $1,702,000 | +27.7% | 25,213 | +7.1% | 0.00% | – |
| Q1 2021 | $1,333,000 | -31.4% | 23,543 | -1.2% | 0.00% | – |
| Q4 2020 | $1,942,000 | +157.9% | 23,841 | +128.9% | 0.00% | – |
| Q3 2020 | $753,000 | -3.3% | 10,414 | +10.0% | 0.00% | – |
| Q2 2020 | $779,000 | +51.6% | 9,464 | +8.3% | 0.00% | – |
| Q1 2020 | $514,000 | -38.6% | 8,740 | +8.0% | 0.00% | – |
| Q4 2019 | $837,000 | -9.1% | 8,094 | -82.2% | 0.00% | – |
| Q3 2019 | $921,000 | +441.8% | 45,491 | +580.1% | 0.00% | – |
| Q2 2019 | $170,000 | +21.4% | 6,689 | -83.6% | 0.00% | – |
| Q3 2018 | $140,000 | -46.4% | 40,698 | -50.2% | 0.00% | – |
| Q2 2018 | $261,000 | -41.0% | 81,678 | -54.7% | 0.00% | – |
| Q1 2018 | $442,000 | -94.6% | 180,258 | -87.6% | 0.00% | -100.0% |
| Q4 2017 | $8,153,000 | +1.6% | 1,455,864 | -0.2% | 0.00% | 0.0% |
| Q3 2017 | $8,026,000 | +1.6% | 1,459,117 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $7,898,000 | +26.9% | 1,435,888 | -10.0% | 0.00% | +100.0% |
| Q1 2017 | $6,224,000 | -42.5% | 1,595,899 | -0.5% | 0.00% | -66.7% |
| Q4 2016 | $10,828,000 | -13.7% | 1,604,239 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $12,552,000 | +5.2% | 1,592,856 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $11,930,000 | -12.6% | 1,582,231 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $13,645,000 | -3.9% | 1,586,656 | +2.0% | 0.00% | -25.0% |
| Q4 2015 | $14,201,000 | – | 1,555,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |